PWM
Prentice Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-81
| Closed | -$8K | – | 145 |
|
|
2022
Q2 | $8K | Buy |
+81
| New | +$8K | 0.01% | 108 |
|
|
2021
Q4 | – | Sell |
-167
| Closed | -$16K | – | 233 |
|
|
2021
Q3 | $16K | Sell |
167
-51
| -23% | -$4.89K | 0.01% | 224 |
|
|
2021
Q2 | $21K | Sell |
218
-8
| -4% | -$771 | 0.01% | 211 |
|
|
2021
Q1 | $22K | Buy |
+226
| New | +$22K | 0.01% | 205 |
|